Chemotherapy in early stage of hormone-resistant metastatic prostate cancer: what are the indications?

Treatment of hormone-refractory prostate cancer remains a source of debate. Since 2004, docétaxel-based chemotherapy has become the standard treatment as it has demonstrated efficacy on overall survival in two randomized studies. In some studies, chemotherapy seems to be also effective on pain relie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Progrès en urologie (Paris) 2010-06, Vol.20 Suppl 3, p.S192-S197
Hauptverfasser:	Drouin, S J, Rouprêt, M, Wallerand, H, Houédé, N
Format:	Artikel
Sprache:	fre
Schlagworte:	Antineoplastic Agents - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Drug Resistance, Neoplasm Humans Male Neoplasm Metastasis Neoplasm Staging Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Taxoids - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!